DKC1 and neuroblastoma: Using microarray assay, von Stedingk et al [44] found DKC1, NHP2 and GAR1 overexpression in high-stage neuroblastoma associated to poor prognosis and genomic complexity, as well as telomere dysfunction, proposing their relationship with tumor aggressiveness.